FMR GLOBAL HEALTH · STRATEGIC ADVISORY
The decisions behind the evidence
Our case studies begin with the commercial challenge, then show the evidence, what it revealed and what decisions it could inform. We distinguish documented findings from recommendations and verified business outcomes.
Evidence-led.
Senior-led.
Decision-ready.
Clarity for healthcare business decisions.
Market potential for a new HIV treatment — France
Challenge: Assess the potential and positioning of a proposed antiretroviral offer in existing treatment pathways. Evidence: Mixed-mode research with 56 treating physicians and 333 patient cases, including treatment algorithms and gain/loss analysis. Findings: An estimate of potential, treatment fit, eligible patient profiles and competitive SWOT. Strategic use: Inputs to positioning and opportunity assessment. No client implementation or commercial outcome is asserted.
Home dialysis awareness and positioning — three European countries
Challenge: Understand competitive awareness, perceptions and experience with home therapies. Evidence: Quantitative interviews with patients or caregivers and dialysis specialists in the UK, Spain and the Netherlands. Findings: Brand and competitive perceptions, information sources, choice drivers and opportunities to improve communication. Strategic use: Inform brand management and communication priorities; outcomes not independently verified.
How we present further work
Business challenge → evidence used → key insights → strategic interpretation → decision supported → recommendation or outcome, clearly labelled. Client approval and source confirmation are required before publishing additional case claims.
Discuss a similar decision
We can explore the challenge even before a formal brief exists.